TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$75 Million

Raptor Pharmaceutical Corp

At-the-market Offering

Provider of bio-pharmaceutical therapies intended to treat diseases that are debilitating and life-threatening. The company's bio-pharmaceutical therapies focuses on developing and commercializing therapies to treat debilitating and often fatal diseases for Huntington's disease, non-fatty liver disease, primary liver cancer & other cancers.